London-listed SPAC targets merger with chronic disease drug developer Istesso
The first “blank cheque” company to list in London after an overhaul aimed at helping the City compete with rival financial centres is in talks… Read More »London-listed SPAC targets merger with chronic disease drug developer Istesso